By Charles Toutant | March 9, 2018
A divided appeals court has ordered a new trial in a medical malpractice suit where defense counsel failed to disclose that the defendant physician's trial testimony was significantly different from his interrogatory answers and deposition testimony.
The Legal Intelligencer | News
By Max Mitchell | March 1, 2018
A hip-implant device with component parts that were subject to different regulatory classifications should be pre-empted by federal law, the U.S. Court of Appeals for the Third Circuit has ruled in an issue of apparent first impression.
By Andrew J. Carlowicz Jr. | March 1, 2018
The holding in this case seems to inject new life into the moribund “Ferreira” conferences in professional liability cases.
By Ross Todd | February 14, 2018
According to the complaint, the former BD employees had access to "technical specifications, source code, and designs," and then downloaded thousands of confidential files prior to leaving the company.
By Brian Baxter | February 12, 2018
Paul Dwyer Jr., who headed a national litigation management team for CVS Health Corp. at Locke Lord, is helping McElroy, Deutsch, Mulvaney & Carpenter move into Rhode Island.
By David N. Crapo | February 9, 2018
The automatic stay does not prohibit a governmental entity from enforcing health-care laws against a debtor.
By Michael Booth | January 30, 2018
A New Jersey appeals court handed Swiss pharmaceutical giant Hoffmann-La Roche a minor victory when it affirmed a trial judge's ruling that four plaintiffs in the Accutane litigation blew the statute of limitations in filing their product liability lawsuits.
By Charles Toutant | January 29, 2018
At opening statements Monday in a Middlesex County court for the second suit linking Johnson & Johnson's talc products to mesothelioma, the company offered several alternate theories for the source of the asbestos that caused the plaintiff's illness.
By David Gialanella | January 25, 2018
A trio of multibillion-dollar deals in three different industries led to a sharp increase in the total amount of value transacted in the 2017 mergers and acquisitions market in New Jersey, data shows.
By Michael Booth | January 25, 2018
New Jersey pharmaceutical regulators are proposing to closely monitor prescriptions for gabapentin, a drug that's nonaddictive but can be misused to enhance the effects of opioids and other addictive drugs.
Presented by BigVoodoo
New Jersey Law Journal honors lawyers leaving a mark on the legal community in New Jersey with their dedication to the profession.
This conference aims to help insurers and litigators better manage complex claims and litigation.
Recognizing innovation in the legal technology sector for working on precedent-setting, game-changing projects and initiatives.
When you come to work for New Jersey Judiciary you will join an 8500-member strong TEAM that operates with the highest standards of independ...
Title: Legal Counsel Reports to: Chief Executive Officer (CEO) FLSA Status: Exempt, Full Time Supervisory Responsibility: N/A Location: Remo...
Blume Forte Fried Zerres and Molinari 1 Main Street Chatham, NJ 07945Prominent Morris County Law Firm with a state-wide personal injury prac...